GALECTIN THERAPEUTICS INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $39.2M | $41.8M | $39.6M |
| FY2022 | $53.5M | $21.3M | $18.6M |
| FY2023 | $88.4M | $28.2M | $25.7M |
| FY2024 | $120.6M | $17.5M | $15.1M |
| FY2025 | $145.7M | $19.5M | $17.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $39.2M | $41.8M | $39.6M |
| FY2022 | $53.5M | $21.3M | $18.6M |
| FY2023 | $88.4M | $28.2M | $25.7M |
| FY2024 | $120.6M | $17.5M | $15.1M |
| FY2025 | $145.7M | $19.5M | $17.7M |